Adult products led Abbott ’s nutritional business sales growth in 2023 and likely will become a stronger driver in 2024 with the launch of a formulation for people using medications rapidly growing in popularity with the addition of a weight loss indication.
Abbott Adding Nutritional For Consumers Using Type 2 Diabetes, Weight Management Drugs
Ensure and Glucerna brand and other adult product sales up 12.5% to account for $1.05bn of $2.04bn in total Q4 nutritionals sales; full-year adult product sales up 6.2%, accounting for $4.2bn of Abbott’s $8.15bn in total nutritionals sales.
More from Earnings
More from Business
• By
By taking a majority stake in dynamic dietary supplements firm Braineffect, Germany's Schwabe can reach a new, younger target audience for its OTC herbal medicines.
• By
A round-up of the latest consumer health industry appointments: GSCF elects chair; Kenvue hires Northern Europe head; Barentz names chief commercial officer.
• By
Bayer Consumer Health hopes its new InflammAge saliva-based biomarker can help “revolutionize self-care and how people can manage their aging journey.”